# US 2012/0253041 A1 · New phenylalanine derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253041 A1
- Document ID: US20120253041A1
- Status: Published application
- Kind: A1
- Application number: 13/524,318
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2000-08-18
- Assignees: Ajinomoto Co., Inc.
- Inventors: Shingo MAKINO; Tatsuya Okuzumi; Toshihiko Yoshimura; Yuko Satake; Nobuyasu Suzuki; Hiroyuki Izawa; Kazuyuki Sagi; Akira Chiba; Eiji Nakanishi; Masahiro Murata; Takashi Tsuji
- Web page: https://patentgrep.com/patent/US20120253041A1

## CPC

- C07D 239/22: with hetero atoms directly attached to ring carbon atoms
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/02: Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/06: Antiasthmatics
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 29/02: without antiinflammatory effect
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61P 37/02: Immunomodulators
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 239/54: as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D 239/78: with hetero atoms directly attached in position 2
- C07D 239/80: Oxygen atoms
- C07D 239/91: with aryl or aralkyl radicals attached in position 2 or 3
- C07D 239/95: with hetero atoms directly attached in positions 2 and 4
- C07D 239/96: Two oxygen atoms
- C07D 253/08: condensed with carbocyclic rings or ring systems
- C07D 265/26: Two oxygen atoms, e.g. isatoic anhydride
- C07D 285/16: Thiadiazines; Hydrogenated thiadiazines
- C07D 285/24: with oxygen atoms directly attached to the ring sulfur atom
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 471/04: Ortho-condensed systems
- C07D 475/02: with an oxygen atom directly attached in position 4
- C07D 487/04: Ortho-condensed systems
- Y02P 20/582: Recycling of unreacted starting or intermediate materials
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α4 integrin. They are used as therapeutic agents for various diseases concerning α4 integrin.

## Claims

### Claim at position 1

1-49. (canceled)

### Claim 50

A compound of formula (1):
wherein:
A represents a group of formula (3):
wherein Arm represents a cyclic alkyl group or an aromatic ring containing 0, 1, 2, 3, or 4 hetero atoms selected from the group consisting of an oxygen atom, a sulfur atom, and a nitrogen atom;
X represents C(═O), S(═O)2, C(—R5)(—R6), C(═C(R5)(R6)), C(═S), S(═O), P(═O)(—OH), or P(—H)(═O);
R2, R3, R4, R5, and R6 may be the same or different from one another and each independently represents a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group, a substituted lower alkyl group, a lower alkenyl group, a substituted lower alkenyl group, a lower alkynyl group, a substituted lower alkynyl group, a cycloalkyl group which may contain a hetero atom(s) in the ring thereof, an aryl group, a heteroaryl group, a lower alkyl group substituted with a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, a lower alkyl group substituted with an aryl group(s), a lower alkyl group substituted with a heteroaryl group(s), a lower alkoxyl group, a lower alkylthio group, a lower alkoxyl group and lower alkylthio group substituted with a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, a lower alkoxyl group and lower alkylthio group substituted with an aryl group(s), a lower alkoxyl group and lower alkylthio group substituted with a heteroaryl group(s), a cycloalkyloxy group which may contain a hetero atom(s) in the ring thereof, an aryloxy group, a heteroaryloxy group, a lower hydroxyalkyl group, a lower hydroxyalkenyl group, a lower hydroxyalkoxyl group, a lower halogenoalkyl group, a lower halogenoalkoxyl group, a lower halogenoalkylthio group, a lower halogenoalkenyl group, nitro group, cyano group, a substituted or unsubstituted amino group, carboxyl group, a lower alkyloxycarbonyl group, a substituted or unsubstituted carbamoyl group, a lower alkanoyl group, an aroyl group, a lower alkylsulfonyl group, a substituted or unsubstituted sulfamoyl group or an ammonium group, R5 and R6 may be bonded together to form a ring which may contain one or two oxygen, nitrogen or sulfur atoms
B represents hydroxyl group, a lower alkoxyl group or hydroxylamino group;
C represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a lower alkyl group substituted with a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, a lower alkyl group substituted with an aryl group(s) or a lower alkyl group substituted with a heteroaryl group(s);
D represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group, a cycloalkyl group which may contain a hetero atom(s) in the ring thereof, an aryl group, a heteroaryl group, a lower alkyl group substituted with a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, a lower alkyl group substituted with an aryl group(s), a lower alkyl group substituted with a heteroaryl group(s), a lower alkoxyl group, a lower alkoxyl group substituted with a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, a lower alkoxyl group substituted with an aryl group(s), a lower alkoxyl group substituted with a heteroaryl group(s), a cycloalkyloxy group which may contain a hetero atom(s) in the ring thereof, an aryloxy group, a heteroaryloxy group, a lower hydroxyalkyl group, a lower hydroxyalkenyl group, a lower hydroxyalkoxyl group, a lower halogenoalkyl group, a lower halogenoalkoxyl group, a lower halogenoalkenyl group, nitro group, cyano group, a substituted or unsubstituted amino group, carboxyl group, a lower alkyloxycarbonyl group, a substituted or unsubstituted carbamoyl group, a lower alkanoyl group, an aroyl group, a lower alkylthio group, a lower alkylsulfonyl group or a substituted or unsubstituted sulfamoyl group;
C and D may be bonded together to form a ring which may contain one or two oxygen, nitrogen, or sulfur atoms;
T represents an interatomic bond, C(═O), C(═S), S(═O), S(═O)2, N(H)—C(═O), or N(H)—C(═S);
J and J′ may be the same or different from each other and each independently represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkyloxy group or a nitro group;
or a pharmaceutically acceptable salt thereof.

### Claim 51 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein Arm represents a benzene ring.

### Claim 52 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein R2, R3, and R4 are each independently a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group, a substituted lower alkyl group, a lower alkoxyl group, a halogen lower alkyl group, substituted or unsubstituted amino group, or an ammonium group.

### Claim 53 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein B represents hydroxyl group or a lower alkoxyl group.

### Claim 54 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein C represents a hydrogen atom or a lower alkyl group.

### Claim 55 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein D represents a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, an aryl group, or a heteroaryl group.

### Claim 56 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein J and J′ each represent a hydrogen atom.

### Claim 57 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein T represents C(═O).

### Claim 58 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein X represents C(═O) or C(═S).

### Claim 59 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein X is C(═O).

### Claim 60 (depends on 50)

A compound or pharmaceutically acceptable salt according to claim 50, wherein:
Arm represents a benzene ring;
R2, R3, and R4 are each independently a hydrogen atom, a halogen atom, a hydroxyl group, a lower alkyl group, a substituted lower alkyl group, a lower alkoxyl group, a halogen lower alkyl group, substituted or unsubstituted amino group, or an ammonium group;
B represents hydroxyl group or a lower alkoxyl group;
C represents a hydrogen atom or a lower alkyl group;
D represents a cycloalkyl group(s) which may contain a hetero atom(s) in the ring thereof, an aryl group, or a heteroaryl group;
J and J′ each represent a hydrogen atom;
T represents C(═O); and
X represents C(═O) or C(═S).

### Claim 61 (depends on 60)

A compound or pharmaceutically acceptable salt according to claim 60, wherein X is C(═O).
